Irish Cancer Society Revenue and Competitors

Dublin, IE

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Irish Cancer Society's estimated annual revenue is currently $15M per year.(i)
  • Irish Cancer Society's estimated revenue per employee is $43,605

Employee Data

  • Irish Cancer Society has 344 Employees.(i)
  • Irish Cancer Society grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M632%N/AN/A
#2
$7.5M93-3%N/AN/A
#3
$7.5M1514%N/AN/A
#4
$15M2148%N/AN/A
#5
$7.5M1465%N/AN/A
#6
$15M1558%N/AN/A
#7
$15M1061-5%N/AN/A
#8
$15M2555%N/AN/A
#9
$15M1417%N/AN/A
#10
$15M96-4%N/AN/A
Add Company

What Is Irish Cancer Society?

We are Ireland's national cancer charity. We listen, we support, we provide care, we create awareness, we provide information, we fund research and we influence decisions about cancer. We are with you on every step of your cancer journey. Visit www.cancer.ie for more details. Cancer Support, Cancer fundraising, Cancer Advocacy, Cancer Research, Nursing

keywords:N/A

N/A

Total Funding

344

Number of Employees

$15M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Irish Cancer Society News

2022-03-22 - Irish Cancer Society marks Daffodil Day in support of cancer patients

The Irish Cancer Society is a vital community of patients, survivors, volunteers, supporters, health and social care professionals and...

2022-03-22 - Daffodil Day collections underway in Carlow and Kilkenny in aid of ...

It's the Irish Cancer Society's largest annual fundraiser and locals are being urged to take part in any way that they can.

2022-03-22 - Daffodil Day returns after two years of Covid disruptions

The Irish Cancer Society is urging members of the public to get out ... The annual appeal is the charity's largest fundraiser of the year,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$117.5M3485%N/A
#2
$3.5M349-12%N/A
#3
$128.7M3556%N/A
#4
$93.2M3551%N/A
#5
$35M3570%N/A